Amneal Pharmaceuticals Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Amneal Pharmaceuticals, Inc. (AMRX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-73.88-48.72-254.7910.6291.06-603.57-201.30
Depreciation & Amortization236.19240.95248.77233.41235.39250.11137.40
Deferred Income Tax0.000.000.000.000.00371.72-9.44
Stock Based Compensation27.7726.8231.8528.4120.750.000.00
Change in Working Capital-4.07-57.02-63.02-133.59-61.32-125.45-0.89
Change in Accounts Receivable-162.16126.29-79.72-23.6216.790.000.00
Change in Inventory-130.53-126.18-102.40-49.02-113.780.000.00
Change in Accounts Payable289.58-84.62111.64-43.930.310.000.00
Change in Other Working Capital4.4244.4117.45-17.0335.370.000.00
Other Operating Activities4.42188.16117.9465.2147.85108.8224.05
Net Cash from Operating Activities295.10345.5865.10241.82379.001.71250.23
Investing Activities
Capital Expenditures-74.99-69.1988.21-50.94-61.8497.43-57.74
Acquisitions11.99-14.50-83.98-146.54-251.3634.83-324.63
Sales/Maturities of Investments0.00-22.39-1.39-1.70-4.3543.020.00
Other Investing Activities-14.650.00-1.395.00-5.3943.020.00
Net Cash from Investing Activities-63.00-69.19-174.31-194.18-317.55-19.58-396.38
Financing Activities
Debt Repayment-233.12-414.08-123.27-79.18-37.01-29.26-784.34
Common Stock Issued0.000.45-1.720.850.320.000.00
Common Stock Repurchased0.00-2.38-3.57-2.66-0.860.000.00
Dividends Paid0.000.000.000.000.000.00-183.00
Other Financing Activities-27.83-235.68-188.90-57.13-10.64-17.96-74.17
Net Cash from Financing Activities-211.79-212.57-106.62-138.12131.81-45.82287.68
Summary
Effect of Forex Changes on Cash-1.000.07-5.680.101.04-2.25-0.67
Net Change in Cash20.3163.88-215.83-90.38194.30-63.69141.53
Cash at Beginning of Period99.1135.23256.74347.12152.82218.7877.92
Cash at End of Period118.42345.5535.23256.74347.12152.84218.78
Free Cash Flow220.11345.58-23.11190.88317.17-95.73153.14
Supplemental Disclosures
Interest Paid263.52192.81142.72121.75130.19158.57131.51
Income Taxes Paid15.222.50-12.6515.56-100.1410.2634.95